PanTera aims to secure the large-scale production of actinium-225 (Ac-225), targeting its use in radiopharmaceuticals for personalized cancer treatment. The company focuses on improving the accessibility of innovative cancer therapies based on Ac-225.

PanTera

SCK CEN is the Belgian Nuclear Research Centre that engages in research and development in the field of nuclear technology, focusing on various nuclear applications and societal challenges.

SCK CEN

The Fedoruk Centre focuses on advancing nuclear science for medical health and environmental sustainability, primarily in Saskatchewan and worldwide. It produces radiopharmaceuticals such as FDG for nuclear imaging and provides funding for nuclear technology innovations.

Metric
Company Name	PanTera	SCK CEN	The Fedoruk Centre
Symbol
MSH ID	COM:PANTERA-LIFE	BE:SCKCEN	CA:FEDORUKCENTRE
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Technology	Healthcare & Health Services
Industry	Biotechnology	Nuclear Research	Nuclear Technology
Country	BE	BE	CA
Stage
Employee Count
Website	pantera-life.com	sckcen.be	fedorukcentre.ca
LinkedIn		sckcen	sylvia-fedoruk-canadian-centre-for-nuclear-innovation
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	3.34K
Web Traffic Growth	0.82
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:PANTERA-LIFE

PanTera

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue